Published in Nature on September 09, 1982
Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med (1994) 2.69
Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci U S A (1986) 2.66
Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes. Proc Natl Acad Sci U S A (1987) 2.16
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood (2005) 2.01
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med (1985) 1.87
Leprosy. Clin Microbiol Rev (1988) 1.74
Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest (1985) 1.71
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
A systematic study of host defense processes in badly injured patients. Ann Surg (1986) 1.60
Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest (1987) 1.55
Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol (1984) 1.50
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol (2006) 1.40
Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity. Immunology (1985) 1.40
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology (2002) 1.36
16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest (1987) 1.33
Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Infect Immun (1988) 1.29
Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol (1990) 1.29
Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol (1985) 1.27
Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti. Clin Exp Immunol (1986) 1.25
B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. Proc Natl Acad Sci U S A (1988) 1.23
Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol (1998) 1.22
HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants. J Exp Med (1985) 1.19
Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance. Infect Immun (1987) 1.19
The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy. Clin Exp Immunol (1985) 1.17
Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology (1990) 1.17
Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest (1989) 1.15
E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. Immunology (2006) 1.13
Murine gamma interferon activates the release of a macrophage-derived Ia-inducing factor that transfers Ia inductive capacity. J Exp Med (1984) 1.13
Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins. Infect Immun (1985) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes. J Exp Med (1991) 1.07
Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest (1985) 1.06
Functional and inducible expression of a transfected murine class II major histocompatibility complex gene. Proc Natl Acad Sci U S A (1984) 1.05
Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate. J Clin Invest (1987) 1.04
Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J Exp Med (1985) 1.03
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. Cell Commun Signal (2012) 1.02
Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J Exp Med (1986) 1.02
Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovani occurs at the level of gene transcription via a cyclic AMP-independent mechanism. Infect Immun (1992) 1.01
Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process. J Exp Med (2013) 1.01
Macrophage function in the Schistosoma mansoni egg-induced pulmonary granuloma. Role of arachidonic acid metabolites in macrophage Ia antigen expression. Am J Pathol (1984) 1.01
Indomethacin in vivo increases the sensitivity to Listeria infection in mice. A possible role for macrophage thromboxane A2 synthesis. J Clin Invest (1987) 1.01
African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages. Clin Exp Immunol (1984) 1.00
Role of lipoxygenase products in murine pulmonary granuloma formation. J Clin Invest (1984) 0.99
Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo. Clin Exp Immunol (1983) 0.96
Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin Exp Immunol (1990) 0.95
Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc Natl Acad Sci U S A (1995) 0.95
Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am J Pathol (1987) 0.94
Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. J Clin Invest (1987) 0.93
Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. Blood (2012) 0.93
Reduction in HLA-DR, HLA-DQ and HLA-DP expression by Leu-M3+ cells from the peripheral blood of patients with thermal injury. Clin Exp Immunol (1989) 0.92
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc (1993) 0.90
Monocyte migration explains the changes in macrophage arachidonate metabolism during the immune response. Proc Natl Acad Sci U S A (1986) 0.90
The alveolar macrophage. Thorax (1985) 0.90
Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis. Ann Rheum Dis (1985) 0.89
The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression. Immunology (1986) 0.86
Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression. Int J Exp Pathol (1992) 0.86
Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophage-dependent glomerulonephritis. Clin Exp Immunol (1990) 0.86
Immune induction of Ia antigens in activated T cells and in kidney epithelial cells in mice. Immunology (1986) 0.85
Expression of MHC class II (Ia) antigen by the neonatal enterocyte: the effect of treatment with interferon-gamma. Immunology (1991) 0.85
Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function. Tissue Eng Part A (2013) 0.85
1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology (1992) 0.85
IL-1-like production in adriamycin-induced nephrotic syndrome in the rat. Clin Exp Immunol (1992) 0.84
Macrophage activity in inflammatory bowel disease. Gut (1990) 0.83
Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci U S A (1987) 0.83
Variable severity and Ia antigen expression in streptococcal-cell-wall-induced hepatic granulomas in rats. Infect Immun (1987) 0.83
In situ localization of interferons in psoriatic lesions. Arch Dermatol Res (1989) 0.82
Regional cellular responses to intraperitoneal infection. Clin Exp Immunol (1992) 0.82
Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J Exp Med (1991) 0.82
Macrophage signal recognition. Agents Actions (1984) 0.81
Isolation and characterization of Hofbauer cells from human placental villi. Arch Gynecol Obstet (1989) 0.81
Interactions between MSCs and immune cells: implications for bone healing. J Immunol Res (2015) 0.81
Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus). Infect Immun (1998) 0.80
Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex. Immunology (1984) 0.80
Alterations in murine macrophage arachidonic acid metabolism following ingestion of nonviable Histoplasma capsulatum. Infect Immun (1992) 0.80
Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin Exp Immunol (2006) 0.80
Piroxicam, indomethacin and aspirin action on a murine fibrosarcoma. Effects on tumour-associated and peritoneal macrophages. Clin Exp Immunol (1991) 0.79
Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut (1994) 0.79
Intercellular regulation of major histocompatibility complex class I expression in neural cells. Immunology (1993) 0.79
Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders. J Exp Med (1988) 0.79
Modulation of murine schistosomiasis by exogenously administered prostaglandins. Am J Pathol (1986) 0.78
Studies on the immunological properties of oxysterols: in vivo actions of 7,25-dihydroxycholesterol upon murine peritoneal cells. Immunology (1990) 0.78
Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. Malar J (2005) 0.78
Lesional modulation of peripheral monocyte leucotactic responsiveness in leprosy. Clin Exp Immunol (1987) 0.78
Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis. Immunology (2001) 0.78
Immune-complex inhibition of macrophage activation is not due to an interaction with the binding or processing of IFN-gamma. Immunology (1988) 0.77
Subcellular localization of the PGE2 synthesis activity in mouse resident peritoneal macrophages. J Exp Med (1984) 0.77
Differential regulation of the release of tumor necrosis factor-alpha and of eicosanoids by mast cells in rat airways after antigen challenge. Mediators Inflamm (2003) 0.76
The relationship between interferon-gamma and keratinocyte alloantigen expression after burn injury. Ann Surg (1995) 0.75
MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha. Immunology (1989) 0.75
Induction of mouse monocyte Ia expression by a mesangial cell-derived product. Clin Exp Immunol (1993) 0.75
Analysis of carrageenan-induced suppression of antibody response. Immunology (1990) 0.75
Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts. Ann Surg (1991) 0.75
Modulation of macrophage Ia expression by lipopolysaccharide: stem cell requirements, accessory lymphocyte involvement, and IA-inducing factor production. Infect Immun (1989) 0.75
Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis. Thorax (1997) 0.75
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. Oncoimmunology (2017) 0.75
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Antigen-presenting function of the macrophage. Annu Rev Immunol (1984) 7.83
Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med (1982) 6.56
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43
Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30
Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 4.85
The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol (1981) 4.72
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70
The regulatory role of macrophages in antigenic stimulation. Adv Immunol (1972) 4.69
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59
The basis for the immunoregulatory role of macrophages and other accessory cells. Science (1987) 4.51
Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. Adv Immunol (1976) 4.18
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol (1981) 3.94
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Activated macrophages induce vascular proliferation. Nature (1977) 3.74
Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol (1982) 3.61
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50
Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev (1991) 3.49
Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. J Immunol (1980) 3.46
Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol (1984) 3.41
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun (1993) 3.38
Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 3.08
A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02
Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex. J Immunol (1979) 2.93
Persistence of immunogenicity of antigen after uptake by macrophages. J Exp Med (1968) 2.93
Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci U S A (1997) 2.89
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
The costimulatory function of antigen-presenting cells. Immunol Today (1990) 2.71
The binding of clathrin triskelions to membranes from coated vesicles. Cell (1981) 2.70
The immune response of mice to antigen in macrophages. Immunology (1968) 2.67
An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65
Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. I. Relationship to cytoplasmic myosin. J Cell Biol (1978) 2.54
The modulation of lymphocyte functions by molecules secreted by macrophages. I. Description and partial biochemical analysis. J Exp Med (1975) 2.54
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Ligand-induced movement of lymphocyte membrane macromolecules. II. Mapping of surface moieties. J Exp Med (1972) 2.49
Antigen binding and capping by lymphocytes of genetic nonresponder mice. J Exp Med (1972) 2.46
The regulation of lymphocyte functions by the macrophage. Immunol Rev (1978) 2.43
Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol (1992) 2.43
Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 2.40
Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med (1980) 2.38
Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA. Proc Natl Acad Sci U S A (1988) 2.26
Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23
T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A (1988) 2.21
Redistribution of myosin accompanying capping of surface Ig. J Exp Med (1977) 2.18
Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Immunol (1981) 2.18
Secretory function of mononuclear phagocytes: a review. Am J Pathol (1976) 2.12
An inhibitor of cell proliferation released by cultures of macrophages. Proc Natl Acad Sci U S A (1974) 2.11
Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol (1991) 2.08
The immunogenicity of antigen bound to the plasma membrane of macrophages. J Exp Med (1970) 2.08
Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med (1973) 2.08
A defect in the antigen-presenting function of macrophages from neonatal mice. Nature (1979) 2.07
Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc Natl Acad Sci U S A (1992) 2.06
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells. Nature (1975) 2.04
Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature (1994) 2.02
Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. J Immunol (1979) 2.00
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Immunity to Listeria infection. Curr Opin Immunol (2000) 1.97
The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products. J Exp Med (1979) 1.97
Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J Immunol (1999) 1.96
Persistence of antigen on the surface of macrophages. Nature (1969) 1.95
Distribution of actin in spreading macrophages: a comparative study on living and fixed cells. J Cell Biol (1983) 1.95
Properties and some uses of anti-macrophage antibodies. Nature (1968) 1.94
Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol (1996) 1.94
Receptor-mediated inactivation of early B lymphocytes. Nature (1975) 1.90
Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens. J Exp Med (1967) 1.90
Redistribution and fate of Ig complexes on surface of B lymphocytes: functional implications and mechanisms. Transplant Rev (1973) 1.88
IA antigens and antigen-presenting function of thymic macrophages. J Immunol (1980) 1.87
The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol (1996) 1.87
Intracellular antibody neutralizes Listeria growth. Immunity (2001) 1.86
Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function. J Immunol (1989) 1.84
Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration. J Immunol (1975) 1.82
Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity (1997) 1.82
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell (1991) 1.81
Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice. J Immunol (1974) 1.79
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
Synthesis and release of thymidine by macrophages. J Immunol (1977) 1.77
Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity (2000) 1.77
Experimental allergic glomerulonephritis induced in the rabbit with homologous renal antigens. J Exp Med (1967) 1.76
Inhibition of surface capping of macromolecules by local anaesthetics and tranquillisers. Nature (1974) 1.75
Calcium-sensitive modulation of Ig capping: evidence supporting a cytoplasmic control of ligand-receptor complexes. J Exp Med (1976) 1.75
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
Endocytosis by lymphocytes of complexes of anti-Ig with membrane-bound Ig. J Immunol (1972) 1.73